Innovating, Optimizing, and Advancing Antithrombotic Treatment in Atrial Fibrillation
WebcastOVERVIEW
Innovating, Optimizing, and Advancing Antithrombotic Treatment in Atrial Fibrillation is organized by Canadian Cardiovascular Society nad would be held during Dec 19, 2016 - Dec 19, 2017. This CME Conference has been approved with a maximum of 1.5 AMA PRA Category 1 Credits.
Conference Objectives are :
• Integrate recent data from randomized trials and national and international databases and registries on the real-world use, effectiveness and safety of oral anticoagulants in patients with AF.
• Consider additional treatment scenarios such as AF with concomitant coronary artery disease and recognize the role of various antithrombotic agents for stroke prevention in such settings.
• Individualize antithrombotic therapy and practice effective DOAC usage in patients with special considerations, whilst balancing risk of bleeding with the benefit of stroke prevention.
Additional details will be posted as soon as they are available.
Conference Objectives are :
• Integrate recent data from randomized trials and national and international databases and registries on the real-world use, effectiveness and safety of oral anticoagulants in patients with AF.
• Consider additional treatment scenarios such as AF with concomitant coronary artery disease and recognize the role of various antithrombotic agents for stroke prevention in such settings.
• Individualize antithrombotic therapy and practice effective DOAC usage in patients with special considerations, whilst balancing risk of bleeding with the benefit of stroke prevention.
Additional details will be posted as soon as they are available.
SPECIALITIES
Hematology Blood and Marrow TransplantQuick Links